Ft. Lauderdale, Florida, March 30, 2020 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation (“eWellness”, “EWLL”, “the Company”), a provider of the state of the art PHZIO platform for the digital physical therapy (“PT”) an telehealth markets announced today that UnitedHealthcare, CIGNA, Anthem Blue Cross and Blue Shield of California have begun full insurance reimbursement for digital physical therapy, it’s also likely that all major health insurance carriers will follow suit.
See our new digital ad that started to run in selected markets over this past weekend.
Are your patients cancelling their appointments due to COVID-19 risk factors? Did you know that Phzio offers virtual care solutions to let you continue seeing patients?
Patients can interact with you online with an interactive video chat. You can prescribe and monitor their home exercises all from the convenience and safety of home.
Book yourself a group demo and training session today for just $49 USD per person and get your patients and practice back on track!
*Providers who complete training will have unlimited free usage of the platform for 30 days and be eligible to receive patient referrals from our site.*
eWellness Healthcare Corporation (OTCQB: EWLL) is the first physical therapy telehealth company to offer real-time distance monitored assessments and treatments. Our business model is to have large-scale employers use our MSK360 and/or our PHZIO platform as a fully PT monitored corporate musculoskeletal (“MSK”) wellness program. The Company’s MSK360 and PHZIO home physical therapy assessment and exercise platform has been designed to disrupt the $30 billion physical therapy market, the $4 billion MSK market and the $8 billion corporate wellness industry. PHZIO re-defines the way MSK physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many MSK physical therapy platform for home use.
For more information on eWellness Healthcare go to:
Safe Harbor Statement
This news release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about eWellness’ beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although eWellness believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. eWellness cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.
For additional information on eWellness Healthcare Corporation and its PHZIO telehealth products please contact Mr. Darwin Fogt, CEO: 1-855-470-1700